Saba Capital Management, L.P.Saba Capital Management, L.P.

Institutional investor · Portfolio as of Q1 2026

SEC EDGAR SourceSEC Filings

Top Holdings390 positions

Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ASAASA
Fund

ASA GOLD AND PRECIOUS MTLS L

5.9M$366.2M10.1%$35.89+46.33%
6 qtrssince 2024-Q4
Increased
66
ECATECAT
Fund

BLACKROCK ESG CAP ALLC TERM

22M$299.1M8.3%$12.84+23.44%
6 qtrssince 2024-Q4
Decreased
0
PDXPDX
Fund

PIMCO DYNAMIC INCOME STRATEG

6.4M$141.5M3.9%$20.68+4.04%
6 qtrssince 2024-Q4
Decreased
0
XGDVXXGDVXDelisted
Fund

GABELLI DIVID & INCOME TR

5.1M$137.5M3.8%$27.68+15.38%
6 qtrssince 2024-Q4
Decreased
0
NFJNFJ
Fund

VIRTUS DIVIDEND INTEREST & P

10.2M$128.8M3.6%$11.94+26.87%
6 qtrssince 2024-Q4
Increased
65
BSTZBSTZ
Fund

BLACKROCK SCIENCE & TECHNOLO

5.5M$122.5M3.4%$19.46+51.45%
6 qtrssince 2024-Q4
Increased
66
GAMGAM
Fund

GENERAL AMERN INVS CO INC

1.8M$107.6M3.0%$47.64+35.46%
6 qtrssince 2024-Q4
Decreased
0
NBXGNBXG
Fund

NEUBERGER NEXT GENERATION

7.5M$97.1M2.7%$11.57+39.39%
6 qtrssince 2024-Q4
Decreased
0
TSLATSLA
PUT

TESLA INC

245,100$91.1M2.5%
Increased
BPREBPRE
Fund

BLUEROCK PVT REAL ESTATE FD

4.8M$79.2M2.2%$15.73-17.78%
2 qtrssince 2025-Q4
Increased
72
NVDANVDA
PUT

NVIDIA CORPORATION

429,000$74.8M2.1%
Increased
PEOPEO
Fund

ADAM NAT RES FD INC

2.3M$62.9M1.7%$19.15+31.91%
6 qtrssince 2024-Q4
Decreased
0
MEGIMEGI
Fund

NYLI CBRE GBL INFR MEGTRNDS

4.1M$60.2M1.7%$10.89+39.97%
6 qtrssince 2024-Q4
Decreased
0
METAMETA
PUT

META PLATFORMS INC

89,200$51M1.4%
New
LEOLEO
Fund

BNY MELLON STRATEGIC MUNS IN

6.1M$38.2M1.1%$5.75+11.04%
6 qtrssince 2024-Q4
Unchanged
0
BABA
PUT

BOEING CO

187,900$37.4M1.0%
Increased
MXFMXF
Fund

MEXICO FD INC

1.8M$36.9M1.0%$18.16+19.14%
4 qtrssince 2025-Q2
Increased
48

FS KKR CAP CORP

3.5M$35.7M1.0%$10.95-1.37%
1 qtr
New
57
RMTRMT
Fund

ROYCE MICRO-CAP TR INC

3M$33.5M0.9%$10.44+34.94%
6 qtrssince 2024-Q4
Increased
46
LQDLQD
ETF

ISHARES TR

300,000$32.7M0.9%$110.84-3.05%
2 qtrssince 2025-Q4
Increased
66
Showing 20 of 390 results.370 more with Pro.PROUpgrade to see all →
$3.6B
AUM
390
Positions
Q1 2026
Filing
Rating · 1.5
Quarterly Portfolio Change
-13%Q1'25$3.7B+15%Q2'25$4.3B-14%Q3'25$3.7B-8%Q4'25$3.4B+8%Q1'26$3.6B
Activity profile
$ moved · Q1'26
New29%Increased30%Decreased26%Exited15%
Composition
Equity vs derivatives
Equity86%Puts14%Calls0%
Holding period
Avg 2.8 quarters
<1Q20%1-4Q39%1-2Y37%2Y+3%

Saba Capital Management, L.P. manages $3.6B across 390 positions as of Q1 2026. Top holdings: ASA (10.1%), ECAT (8.3%), PDX (3.9%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1.5/5.0.

Q1 2026 Summary

Active quarter - 86 new positions, 54 exits, 57 increased. Top move: BPRE (INCREASED, conviction 72). Portfolio: $3.6B across 390 positions.

Top holdings by portfolio weight

Total AUM$3B
ASA10.12%
ECAT8.26%
PDX3.91%
XGDVX3.80%
NFJ3.56%
BSTZ3.38%
GAM2.97%
NBXG2.68%
BPRE2.19%
PEO1.74%
Other1.66%

Portfolio allocation by GICS sector

Sectors11
Unknown75.25%
Financial Services10.40%
Technology4.57%
Communication Services3.24%
Consumer Cyclical2.71%
Industrials1.86%
Real Estate0.62%
Healthcare0.58%
Consumer Defensive0.53%
Basic Materials0.18%
Other0.08%

Behavioral investing profile

Momentum Trader94%- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record48
Conviction35
Concentration64
Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
CODICOMPASS DIVERSIFIED
Q1 2025 Q1 2026+350,788 shares+$1.6M
5Q
GFNEW GERMANY FD INC
Q1 2025 Q1 2026+1M shares+$14.2M
4Q
RMTROYCE MICRO-CAP TR INC
Q2 2025 Q1 2026+2.9M shares+$33.1M

Upgrade to Pro to see all accumulation streaks

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used